Literature DB >> 29805927

Long-term Quality of Life in Survivors of Brain Metastases: A Roller Coaster of Perspective.

Naveen Kumar Reddy1, Franklin C Brown2, Miklos C Fogarasi3, James B Yu4, Judith Hess5, Veronica S Chiang6.   

Abstract

Longevity in cancer patients with brain metastases is increasingly being observed. This raises discussions about how best to maintain a good quality of life for these patients. Recent data suggest that post-treatment quality of life (QoL) can be maintained using new treatment options, but little data exist regarding the QoL in long-term survivors. This study of 19 patients surviving greater than two years from the initial treatment of brain metastases suggests that long-term QoL can be better than at the start of treatment and perhaps even better than normal, especially between three and five years post-treatment. This improved QoL seems mostly attributable to improved functional and social well-being and is possible as long as emotional and physical well-being are maintained within the normal range.

Entities:  

Keywords:  brain metastasis; breast cancer survivors; gamma knife radiosurgery; long-term toxicity; quality of life; radiation oncology; stereotactic radiosurgery

Year:  2018        PMID: 29805927      PMCID: PMC5963947          DOI: 10.7759/cureus.2358

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  5 in total

1.  Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort.

Authors:  Bente Sandvei Skeie; Geir Egil Eide; Marianne Flatebø; Jan Ingeman Heggdal; Elisabeth Larsen; Sidsel Bragstad; Paal-Henning Pedersen; Per Øyvind Enger
Journal:  J Neurosurg       Date:  2016-04-08       Impact factor: 5.115

Review 2.  Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.

Authors:  Kirtesh R Patel; David H Lawson; Ragini R Kudchadkar; Bradley C Carthon; Daniel E Oliver; Derick Okwan-Duodu; Rafi Ahmed; Mohammad K Khan
Journal:  Neuro Oncol       Date:  2015-05-25       Impact factor: 12.300

3.  Psychometric validation of the functional assessment of cancer therapy--brain (FACT-Br) for assessing quality of life in patients with brain metastases.

Authors:  Nemica Thavarajah; Gillian Bedard; Liying Zhang; David Cella; Jennifer L Beaumont; May Tsao; Elizabeth Barnes; Cyril Danjoux; Arjun Sahgal; Hany Soliman; Edward Chow
Journal:  Support Care Cancer       Date:  2013-11-28       Impact factor: 3.603

4.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

Review 5.  Cognitive deficits in adult patients with brain tumours.

Authors:  Martin J B Taphoorn; Martin Klein
Journal:  Lancet Neurol       Date:  2004-03       Impact factor: 44.182

  5 in total
  1 in total

1.  LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy.

Authors:  Carsten Nieder; Rosalba Yobuta; Bård Mannsåker
Journal:  Cureus       Date:  2020-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.